Dark

PFE
Pfizer Inc.
stock NYSE

At Close

May 28, 2025 3:59:59 PM EDT

23.17USD-1.864%(-0.44)36,634,022

23.17Bid 23.18Ask 0.01Spread

Pre-market

May 28, 2025 9:29:43 AM EDT

23.58USD-0.127%(-0.03)92,886

After-hours

May 28, 2025 4:44:30 PM EDT

23.20USD+0.129%(+0.03)336,693

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

07:47AM EST Pfizer Inc. (PFE) and Ionis Pharmaceuticals, Inc. (IONS) announced the discontinuation of the Pfizer-led clinical development program for vupanorsen, an investigational antisense therapy. Also, Pfizer will return development rights to vupanorsen to Ionis. RTTNews

07:16AM EST Pfizer And Ionis Announce Discontinuation Of Vupanorsen Clinical Development Program Benzinga

07:08AM EST Pfizer, Ionis Announce Discontinuation Of Vupanorsen Clinical Program For CV Risk Reduction And Hypertriglyceridemia RTTNews

07:05AM EST Pfizer and Ionis announce discontinuation of vupanorsen clinical development PR Newswire

05:29AM EST Pfizer and Alex Therapeutics Announced a Strategic Commercial Partnership to Provide Evidence-based Digital Therapeutics to Patients, Starting in Germany Benzinga

Jan 28, 2022

12:04PM EST Pfizer Whale Trades For January 28 Benzinga

11:43AM EST Sorrento's COVID-19 Main Protease Inhibitor Neutralizes Omicron Benzinga

10:01AM EST Pfizer Inc. (PFE) said Friday that the European Commission granted marketing authorization for Lorviqua or lorlatinib as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase or ALK- positive advanced non-small cell lung cancer or NSCLC previously not treated with an ALK inhibitor. RTTNews

09:54AM EST Pfizer : European Commission Approves LORVIQUA As First-Line Treatment For ALK-Positive Advanced Lung Cancer RTTNews

09:48AM EST Pfizer Announces European Commission Granted Marketing Authorization Of LORVIQUA Benzinga

09:46AM EST European Commission Approves LORVIQUA(r) (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer Business Wire

Jan 27, 2022

03:16PM EST Australia's TGA Says Pfizer's COVID-19 Vaccine Provisionally Approved For Use As A Booster In Individuals Aged 16-17 Years Old; Continues To Monitor Ongoing Trials Associated With Booster Doses For Younger Children Benzinga

10:54AM EST Pfizer Option Alert: Feb 11 $55.5 Calls Sweep (31) near the Ask: 460 @ $1.28 vs 62 OI; Earnings 2/8 Before Open Ref=$54.08 Benzinga

09:27AM EST Pfizer Obtains CHMP Positive Opinion For COVID-19 Oral RTTNews

09:16AM EST Pfizer Receives CHMP Positive Opinion For Novel COVID-19 Oral Treatment Benzinga

09:14AM EST Pfizer Receives CHMP Positive Opinion For COVID-19 Oral Treatment RTTNews

09:11AM EST Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment Business Wire

Jan 26, 2022

06:13AM EST Bloomberg Reported BioNTech to Boost Staff by 50% at Biggest German Vaccine Factory Benzinga

Jan 25, 2022

10:07AM EST Shares of vaccine manufacturer BioNTech SE (BNTX) are rising 5 percent on Tuesday's trading after the company and its partner Pfizer Inc. (PFE) announced the initiation of a clinical trial to evaluate an Omicron-based vaccine candidate in adults aged between 15 and 55 years. RTTNews

09:16AM EST Cannabis Movers & Shakers: Flora Growth, The Green Organic Dutchman, Trade Roots And TrueGreen Benzinga

07:46AM EST The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data Benzinga

07:23AM EST Pfizer Inc. (PFE) and BioNTech SE (BNTX) on Tuesday announced the initiation of a clinical trial to evaluate an Omicron-based vaccine candidate in adults 15 to 55 year of age. RTTNews

06:51AM EST Pfizer And BioNTech Initiate Study To Evaluate Omicron-Based COVID-19 Vaccine In Adults 18 To 55 Years Of Age RTTNews

06:46AM EST Pfizer And BioNTech Initiate Study To Evaluate Omicron-Based COVID-19 Vaccine In Adults 18-55 Years Of Age Benzinga

Jan 24, 2022

10:28PM EST FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why Benzinga

06:18PM EST Check Out What Whales Are Doing With PFE Benzinga

02:17PM EST Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments? Benzinga

12:44PM EST Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows Benzinga

07:58AM EST From Oxford: Third Booster Of Either AstraZeneca, Pfizer, Janssen Or Sinovac COVID Shot Induce Higher Antibodies In Those Who Previously Got Two Sinovac Doses Benzinga

06:59AM EST Pfizer and BioNTech Publish Data From Two Lab Studies on Covid-19 Vaccine-induced Antibodies Ability to Neutralize SARS-COV-2 Omicron Variant; Both Data Sets Confirm Previously Announced Initial Study Results Demonstrating That Serum Antibodies Induced by BNT162B2 Neutralize the SARS-COV-2 Omicron Variant After Immunization With Three Doses Benzinga

06:11AM EST A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge Benzinga

Jan 23, 2022

09:42PM EST Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has acquired a stake in Unilever Plc. (UN, ULVR.L, UL), adding pressure on the Dove soap maker, after Unilever's failed bid to buy a Consumer Healthcare business from GlaxoSmithKline Plc. (GSK.L, GSK), according to several reports citing people familiar with the matter. RTTNews

Jan 21, 2022

04:31PM EST Pfizer, OPKO Health Report FDA Issued Complete Response Letter For Biologics License Application For Their Somatrogon Benzinga

04:30PM EST Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Business Wire

10:36AM EST French Health Authority Authorizes Early Access To Pfizer's Paxlovid Treatment For Adults With COVID Infection Benzinga

08:41AM EST Lower COVID-19 Vaccine Sales Estimated Amid Less Severe Omicron Variant: Bloomberg Benzinga

08:21AM EST WHO Vaccine Advisory Group's Head Says Children Aged 5-11 Yrs A Low-Priority Use Group For Pfizer Vaccine, Except Those With Comorbidities Benzinga

05:16AM EST This Is What Whales Are Betting On Pfizer Benzinga

05:11AM EST Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field Benzinga

Jan 20, 2022

11:34AM EST Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters Benzinga

08:12AM EST Japan's Ministry Of Health, Labour And Welfare Approves Pfizer And OPKO's NGENLA (Somatrogon), A New Long-Acting Treatment For Pediatric Growth Hormone Deficiency Benzinga

01:11AM EST Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine Benzinga

Jan 19, 2022

04:07PM EST Watching Vaccine And COVID-19 Testing Names As Biden In Speech Highlights Vaccination Progress, Encourages Boosters; Highlights Free Home Test Kits And Recent Purchase Of Pfizer Antiviral Pills Benzinga

08:26AM EST Pfizer's COVID-19 Oral Antiviral Shows In-Vitro Efficacy Against Omicron Variant Benzinga

07:29AM EST Wall Street Journal Reported Yesterday 'Pfizer's New Covid-19 Pill Works Against Omicron in Lab' Benzinga

Jan 18, 2022

01:03PM EST BZ NOTE: Report On Pfizer/BioNTech Vaccine Fourth Shot Study Results Via Israeli Lab Was Reported Monday Via Reuters Benzinga

01:01PM EST Pfizer Shares Quiet Amid FT Report 'Fourth Pfizer jab ineffective in blocking Omicron, Israeli study shows' Benzinga

11:39AM EST WHO Chief Scientist Soumya Swaminathan Says There Is No Evidence Right Now That Healthy Children, Healthy Adolescents Need COVID-19 Boosters Benzinga

10:13AM EST EU Regulator Says No Evidence Seen Yet To Recommend 4th Dose Of COVID-19 Vaccines Benzinga

09:39AM EST Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition Benzinga

06:34AM EST Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal Benzinga

06:33AM EST FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis Benzinga

05:44AM EST Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed Benzinga

02:03AM EST 4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers Benzinga

Jan 17, 2022

10:54AM EST Preliminary Study at Israeli Hospital Shows Fourth Shot of Pfizer/Biontech or Moderna Vaccine Leads to Higher Level of Antibodies Than After Third Shot, But Fourth Shot Is Still Not Effective Enough to Prevent Omicron Infection Benzinga

10:50AM EST Pfizer CEO Albert Bourla Said Monday Coronavirus will be Circulating for Many Years to Come, But Said Thinks Current Wave of Infections will be Final One that Requires Restrictions Benzinga

10:39AM EST Canada Approved Pfizer's COVID-19 Oral Antiviral Treatment Benzinga

Jan 15, 2022

02:17PM EST GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit Benzinga

Jan 14, 2022

03:31PM EST Pfizer Reports FDA Approval For CIBINQO For Adults with Moderate-To-Severe Atopic Dermatitis Benzinga

03:30PM EST U.S. FDA Approves Pfizer's CIBINQO(r) (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis Business Wire

01:25PM EST Federal Health Officials Say Omicron-Targeted Shots May Not Be Necessary: WSJ Benzinga

Jan 13, 2022

02:30PM EST Supreme Court Blocks President Biden's Workplace Vaccine-Or-Test Mandate For Larger Employers; Grants Administration Request To Enforce Vaccine Mandate For Healthcare Workers Nationwide Benzinga

12:55PM EST Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares Benzinga

12:24PM EST Is The Launch Of A New Fund A Sell Signal For An Asset? Examples From Health Care, Commodities, And Now Bitcoin. Benzinga

Jan 12, 2022

01:02PM EST WHO's Technical Body Says Updated COVID-19 Vaccines Needed To Combat Omicron: Reuters Benzinga

10:42AM EST New Data Supports Co-Administration Of Pfizer's Pneumococcal, COVID-19 Vaccine Benzinga

08:30AM EST The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award Benzinga

08:05AM EST Pharma major Pfizer Inc. (PFE) on Wednesday unveiled positive top-line results from a Phase 3 study, describing the safety and immunogenicity of Prevnar 20, a pneumococcal conjugate vaccine. RTTNews

07:15AM EST Pfizer Announces Positive Top-line Results From Phase 3 Study Of PREVNAR 20 RTTNews

06:49AM EST Pfizer Reports Positive Results Of Phase 3 Study Exploring Coadministration Of PREVNAR 20 With COVID-19 Vaccine RTTNews

06:47AM EST Pfizer Announces Results From A Phase 3 Study Of Safety And Immunogenicity Of PREVNAR 20 With Pfizer-BioNTech COVID-19 Vaccine In Older Adults Benzinga

06:45AM EST Positive Top-Line Results of Pfizer's Phase 3 Study Exploring Coadministration of PREVNAR 20(tm) With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released Business Wire

Jan 11, 2022

03:24PM EST Pfizer To Cut Its US Sales Force By 'A Few Hundred,' Cites Move By Team To Move Meetings More Toward Virtual Benzinga

10:25AM EST EU Drug Regulator Says Should Be Careful In Not Overloading Immune System With Repeated COVID-19 Immunization Benzinga

10:12AM EST EU Drug Regulator Evaluating Application To Extend Use Of Pfizer-BioNTech Shot As Booster For 16-17 Year Olds, Expect Cos To Apply For Boosters In 12-15 Group As Well Benzinga

09:30AM EST Dren Bio Announces Research Collaboration, License Agreement With Pfizer To Discover, Advance Multiple Therapeutic Antibodies Using Targeted Myeloid Engager, Phagocytosis Platform For Treatment Of Cancer Benzinga

Jan 10, 2022

05:01PM EST Pfizer (PFE) CEO Albert Bourla on Monday said that Covid vaccine for omicron variant will be ready in March. RTTNews

03:38PM EST Pfizer Whale Trades Spotted Benzinga

03:16PM EST From JP Morgan Healthcare Conference: Pfizer Expects To Have 30M Courses Of Co.'s Antiviral COVID Pill Paxlovid By End Of Q2'22 Benzinga

03:15PM EST From JP Morgan Healthcare Conference: Pfizer Says Remaining 90M Courses Of Antiviral COVID Pill Paxlovid Expected In 2022 Will Be Produced Equally In Q3, Q4 Benzinga

03:14PM EST From JP Morgan Healthcare Conference: Pfizer Sees Having 6M-7M Courses Of Co.'s Antiviral COVID Pill Paxlovid By End Of Q1 Benzinga

03:11PM EST From JP Morgan Healthcare Conference: Pfizer Is Ready To File, Launch Omicron-Specific Vaccine In March Benzinga

03:10PM EST Pfizer Says It Has Started Producing An Omicron-Specific Variant Already, Sees Omicron Updated Vaccine As The Most Likely Outcome Benzinga

12:50PM EST Pfizer's Omicron-Targeted Vaccine Expected To Be Ready In March: CEO Says On CNBC Benzinga

11:04AM EST 'Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January' -Business Inside Benzinga

09:02AM EST EMA Receives Application For Conditional Marketing Authorization For Paxlovid For Treating Patients With COVID-19; Says Will Assess Benefits And Risks Of Paxlovid Under A Reduced Timeline And Could Issue An Opinion Within Weeks Benzinga

08:22AM EST Pfizer CEO Says Working On A New Verse Of Vaccines Effective Against Omicron As Well As Other Variants Benzinga

08:21AM EST Pfizer CEO Says Don't Know If There Is A Need For A 4th Booster Benzinga

07:41AM EST The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming Benzinga

06:53AM EST Pfizer (PFE) said that it has entered into an agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics. RTTNews

06:41AM EST Pfizer Enters Into Agreement With Acuitas Therapeutics For Lipid Nanoparticle Delivery System For Use In mRNA Vaccines And Therapeutics Benzinga

06:38AM EST Pharma major Pfizer Inc. (PFE), and Beam Therapeutics Inc. (BEAM), a company focused on genetic medicines through base editing, entered into an exclusive four-year research collaboration aimed at vivo base editing programs for three targets for rare genetic diseases of the liver, muscle, and central nervous system. RTTNews

06:35AM EST Pfizer Reaches Deal With Acuitas For Lipid Nanoparticle Delivery System For Use In MRNA Vaccines And Therapeutics RTTNews

06:30AM EST Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics Business Wire

06:05AM EST Pfizer And Beam Therapeutics Enter Research Collaboration To Advance Novel In Vivo Base Editing Programs RTTNews

06:04AM EST Pfizer, Beam Enter Exclusive Multi-Target Research Collaboration To Advance Novel In Vivo Base Editing Programs For A Range Of Rare Diseases; Beam Will Receive An Upfront Payment Of $300M, Be Eligible To Receive Future Milestone Payments Of Up To $1.05B Benzinga

06:00AM EST Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases Business Wire

06:00AM EST Pfizer and Beam Enter Exclusive Multi-Target Research GlobeNewswire Inc

Jan 7, 2022

01:08PM EST Wells Fargo Maintains Overweight on Pfizer, Raises Price Target to $65 Benzinga

Jan 6, 2022

03:21PM EST The Centers for Disease Control and Prevention has widened the eligibility of Pfizer Inc. (PFE) and BioNTech SE's booster doses to children aged between 12 and 15 years old. RTTNews

01:54PM EST White House Says Vaccine Mandates Related To Schools Are Always Up To School Districts Benzinga

10:32AM EST Pfizer Whale Trades Spotted Benzinga

Jan 5, 2022

05:10PM EST CDC Advisers Vote In Favor Of Recommending Pfizer, BioNTech COVID-19 Vaccine Booster Dose For Ages 12-17 Years Old Benzinga

02:48PM EST CDC Recommends Pfizer Booster Shot At 5 Months; Additional RTTNews

02:03PM EST Analyst Ratings For Pfizer Benzinga

12:18PM EST Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays Benzinga

10:09AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022 Benzinga

08:20AM EST The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets Benzinga

07:44AM EST After Successful COVID-19 Vaccine, Pfizer, BioNTech Come Together For mRNA-Based Shingles Vaccine Benzinga

07:30AM EST Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and Pfizer Inc. (PFE) have completed the collaboration transaction for commercialization of Rimegepant and Zavegepant outside U.S. These agreements have become effective following the receipt of required regulatory approvals. RTTNews

07:13AM EST Pfizer, BioNTech Join To Develop MRNA-based Vaccine RTTNews

07:11AM EST B of A Securities Upgrades Pfizer to Buy, Raises Price Target to $70 Benzinga

07:03AM EST Biohaven, Pfizer Complete Collaboration Transaction For Commercialization Of Rimegepant And Zavegepant Outside US RTTNews

07:01AM EST Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of PR Newswire

06:51AM EST Pfizer, BioNTech Sign New Global Collaboration Deal To Develop First MRNA-based Shingles Vaccine RTTNews

06:47AM EST Pfizer And BioNTech Sign New Global Collaboration Agreement To Develop mRNA-based Shingles Vaccine; BioNTech to Receive $225M Upfront, Pfizer To Receive $25M For Proprietary Antigen Sequences Identified By Pfizer Benzinga

06:45AM EST Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine Business Wire

Jan 4, 2022

10:05PM EST LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA PR Newswire

01:31PM EST U.S. Administration Expects 4M COVID Anti-Viral Treatments Available By End Of Jan., 10M By June Benzinga

11:45AM EST Pfizer Reports Will Provide US Gov't. With Added 10M Treatment Courses Of Its Oral Antiviral Pill For COVID-19 Benzinga

11:45AM EST Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19 Business Wire

10:00AM EST Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire

09:42AM EST UPDATE: CDC Says Booster Interval Recommendation For People Who Receive J&J Vaccine (2 Months) Or Moderna Vaccine (6 Months) Has Not Changed Benzinga

09:37AM EST CDC Recommends Pfizer Booster At 5 Months, Additional Primary Dose For Certain Immunocompromised Children Benzinga

Jan 3, 2022

01:19PM EST CDC to Hold Advisory Meeting on January 5 to Discuss Pfizer Covid-19 Vaccine Booster for 12-15 Year Olds Benzinga

11:19AM EST Ten Biggest Weed Stories Of 2021: Big Pharma, Delta-8, Tech, Silicon Valley, MSOs, Politics And More Benzinga

10:24AM EST Starbucks To Require U.S. Vaccination Disclosure By Jan. 10; Unvaccinated Workers Will Need Weekly COVID Tests Benzinga

10:07AM EST U.S. Food and Drug Administration has expanded the emergency use authorization of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 12 years of age and older. The booster dose is the same dosage strength (30-microgram) as the dose approved in the primary series, the companies said in a statement. RTTNews

09:56AM EST 'FDA...shortens time between Pfizer 2nd dose and booster to at least 5 months...' -Tweet From CNBC Pharma Reporter Meg Tirrell Benzinga

09:53AM EST Pfizer , BioNTech Receive U.S. FDA Emergency Use Authorization Of COVID-19 Vaccine Booster For 12 Years Of Age And Older RTTNews

09:45AM EST Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older Business Wire

09:37AM EST FDA Authorizes Pfizer Booster For People 12-15 Years Old Benzinga

07:23AM EST Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters Benzinga

06:43AM EST FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck Benzinga

Dec 31, 2021

02:03PM EST Mid-Afternoon Market Update: Dow Rises 50 Points; Nutriband Shares Spike Higher Benzinga

12:07PM EST Mid-Day Market Update: Crude Oil Down 1%; Xeris Biopharma Shares Jump Benzinga

10:01AM EST Mid-Morning Market Update: Markets Edge Lower; UK Approves Pfizer's Oral COVID-19 Antiviral Treatment Benzinga

08:17AM EST The U.K. Medicines and Healthcare products Regulatory Agency said Friday that it has approved Pfizer's Oral COVID-19 antiviral medicine, Paxlovid, for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19. RTTNews

08:07AM EST Pfizer's Oral COVID-19 Antiviral Treatment Paxlovid Approved For Use In UK Benzinga

06:23AM EST Pfizer's Oral COVID-19 Antiviral, Paxlovid, Approved By UK Regulator; Regulators Say Too Early To Know Whether Omicron Variant Has Any Impact On Paxlovid's Effectiveness Benzinga

Dec 30, 2021

03:32PM EST 'Province set to announce fourth dose of COVID-19 vaccine for nursing home residents' -Toronto Star Report Benzinga

01:58PM EST Pfizer COVID Vaccine Safe For Children Aged 5 To 11 Benzinga

01:11PM EST Jazz Pharmaceuticals Begins Enrollment For Clinical Trial To Evaluate JZP150 For Adults With PTSD Benzinga

11:47AM EST 'F.D.A. Is Said to Be Near Allowing Boosters for 12- to 15-Year-Olds' -New York Times Report Benzinga

10:17AM EST This Industry Grew During Covid, Against All Odds: Here's Why You Should Consider Investing Benzinga

10:00AM EST Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire

06:31AM EST Beximco Pharma Introduces Generic Version Of Pfizer's Paxlovid Covid-19 Treatment In Bangladesh RTTNews

Dec 29, 2021

04:49PM EST Select Walmart And Sam's Club Pharmacies Announce Are Ready To Dispense Authorized COVID-19 Antiviral Medication Through Federal Retail Pharmacy Therapeutics Program Benzinga

10:15AM EST Pfizer Whale Trades For December 29 Benzinga

08:01AM EST FDA Is Looking At Boosters For Kids 12-15 Benzinga

Dec 28, 2021

10:00AM EST Pfizer Invites Public to View and Listen to Webcast of February 8 Conference Call with Analysts Business Wire

Dec 27, 2021

04:06PM EST Goldman Sachs Spokesperson Says Starting In Feb, Anyone Eligible To Get Booster Shot Will Be Required To Have One To Enter Goldman Offices In US Benzinga

10:20AM EST Israel Shortens Time Between Administering 2nd And 3rd COVID-19 Vaccine Doses To 3 Months From 5 Months, Health Ministry Says Benzinga

Dec 26, 2021

09:53AM EST The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year Benzinga

Dec 23, 2021

03:01PM EST How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch? Benzinga

12:20PM EST Oxford Lab Study Suggests AstraZeneca's COVID-19 Booster Works Against Omicron Benzinga

12:13PM EST UK Says COVID Omicron Variant Hospital Risk 50-70% Lower Than Compared To Delta Variant Benzinga

11:28AM EST FDA Official Says Available Data Indicates Merck, Pfizer's COVID Antiviral Pills Are Effective Against Omicron Benzinga

11:18AM EST 'New Jersey reports more than 15,000 new COVID cases, more than double the pre-omicron record and up almost 60% in just one day' -Tweet From NBC New York Benzinga

10:05AM EST Pfizer, BioNTech, Moderna Shares Quiet Following Updated Data On COVID Vaccine For Ages 12-15 From Pfizer, BioNTech Benzinga

10:04AM EST UPDATE: Pfizer, BioNTech Say 2-Dose Series Of COVID Vaccine In Ages 12-15 Showed 100% Effective 4 Months After Second Dose Benzinga

10:03AM EST Pfizer, BioNTech Report Submission Of Updated Longer-Term Follow-Up Data On COVID Vaccine In Ages 12-15 Years To European Medicines Agency Benzinga

09:41AM EST FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck Benzinga

05:56AM EST U.S. Equity Futures Higher Ahead of Christmas Weekend; Positive News on Effectiveness of Vaccines Against Omicron Variant Benzinga

Dec 22, 2021

05:39PM EST 'White House warns Pfizer Covid-19 pill will not be widely available for months' -Recent FT Article Benzinga

03:54PM EST 'New York reports 28,924 new coronavirus cases, the biggest one-day increase on record, of which 17,221 are in New York City' -Tweet From BNO Newsroom Benzinga

03:46PM EST White House Covid-19 Response Coordinator Zients Says Anti-viral Treatments Will Be Provided to States, Localities at No Charge Benzinga

03:36PM EST Pfizer Shares Quiet; White House COVID Advisor Says US Gov't. Will Provide Any Resources Needed To Pfizer For Production Of Its Antiviral COVID Pill Benzinga

03:35PM EST White House Advisor Dr. Fauci Says Attending Large Gatherings Of 40+ People Is Not Considered Safe For Vaccinated, Boosted People Benzinga

03:28PM EST US Pres Joe Biden Says His Admin. Will Work With States To Ensure Pfizer's Antiviral Pill Is Distributed Equitably, Hardest-Hit Communities Are Reached Benzinga

03:26PM EST 'In @WHCOVIDResponse briefing, Zients gives update on supply in what he calls the nation's medicine cabinet for #covid19. In Jan.: 265K courses of Pfizer drug, 3M of Merck drug (if authorized), 500K+ of AZN preventive antibody, 300K of Vir/GSK antibody' Benzinga

01:38PM EST Top 10 WallStreetBets Mentions for December 22, 2021 Since Market Open: TSLA, NVDA, GME, AMD, BABA, AAPL, PFE, AMC, PLTR, DTE Benzinga

01:27PM EST The U.S. Food and Drug Administration on Wednesday granted Emergency Use Authorization to Pfizer's (PFE) Covid-19 oral anti-viral pill, a breakthrough approval that experts believe will help in the battle against coronavirus. RTTNews

12:49PM EST White House Says Has Purchased 10M Doses Of Antiviral COVID Pill From Pfizer, 3M Doses From Merck Benzinga

12:41PM EST US President Biden Notes Current Goal Of Pfizer Is To Have ~30M Paxlovid Antiviral COVID Pill Treatments Available By Middle Of 2022 Benzinga

12:26PM EST Pfizer Planning To File New Drug Application With FDA For Full Regulatory Approval Of Its COVID Antiviral Pill In 2022 Benzinga

12:24PM EST Pfizer Receives FDA Emergency Use Authorization For Novel COVID-19 Oral Antiviral Treatment RTTNews

12:20PM EST FDA Issues Emergency Use Authorization for Pfizer's Paxlovid Oral Antiviral Treatment for Covid-19 Benzinga

12:19PM EST Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment Business Wire

12:17PM EST FDA Issues Emergency Use Authorization for Pfizer's Paxlovid Oral Antiviral Treatment for Covid-19 Benzinga

11:22AM EST Study Out Of Scotland Shows Risk Of Hospital Admission For Patients With COVID Omicron Variant Reduced By 2/3 vs Delta Variant Benzinga

09:40AM EST UK Regulator Has Approved Use Of Pfizer/BioNTech Vaccine In 5-10 Year Olds Benzinga

09:18AM EST FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg Benzinga

09:16AM EST UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer Benzinga

07:42AM EST The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda Benzinga

05:38AM EST U.S. Equity Futures Lower, European Markets Mixed; Governments Across the World Tighten Restrictions Due to Omicron Surge; Tech Companies Cancel Out of CES Vegas Event Benzinga

03:14AM EST Pfizer Inc. (PFE) said that it will supply the United Kingdom an additional 2.5 million treatment courses of its investigational candidate PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets). RTTNews

02:58AM EST Pfizer To Provide UK Addl 2.5 Mln Treatment Courses Of Investigational Oral Antiviral Candidate To Help Combat COVID-19 RTTNews

02:53AM EST Pfizer to Provide the United Kingdom an Additional 2.5 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19 Business Wire

Dec 21, 2021

03:36PM EST 'Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers.' -Israel Reporter Tweet Benzinga

03:33PM EST Reporter Amichai Stein Tweets: Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers Benzinga

03:23PM EST 'Chicago to require proof of vaccination at restaurant, bars' -CNBC Benzinga

12:47PM EST Five-Year Follow-Up Data Show Pfizer's Tafamidis Cuts Risk of Mortality by 41% In Cardiomyopathy Patients Benzinga

11:08AM EST What Are Whales Doing With Pfizer Benzinga

10:24AM EST NYC Mayor's Office Tweets '@NYCMayor just announced a new $100 incentive for New Yorkers if they get their booster shot at City-run sites before December 31.' Benzinga

08:12AM EST The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail Benzinga

07:55AM EST Germany's Stiko Vaccine Authority Recommends Boosters With mRNA Vaccines for Over 18s Three Months After Second Shot. Benzinga

06:42AM EST Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option Benzinga

02:26AM EST ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi Limited as shareholders, said that the US Food and Drug Administration approved Apretude, long-acting injectable pre-exposure prophylaxis option to reduce the risk of sexually acquired HIV-1. RTTNews

Dec 20, 2021

04:36PM EST Pfizer's VYNDAQEL Reduced Risk Of All-Cause Mortality By 41% Among Patients With Transthyretin Amyloid Cardiomyopathy RTTNews

04:32PM EST Pfizer Announces It's VYNDAQEL/VYNDAMAX Reduced The Risk Of All-Cause Mortality By 41% Among Patients With Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data Demonstrate Benzinga

04:31PM EST New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer's (PFE) Covid-19 vaccine after the man died probably due to myocarditis after taking his first dose. RTTNews

04:30PM EST Pfizer's VYNDAQEL(r)/VYNDAMAX(r) Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data Demonstrate Business Wire

02:43PM EST Biden Admin. Has Pushed Bank Enforcement Of New Vaccine Rules Benzinga

11:34AM EST WHO's Chief Scientist Says 'Very Dangerous' To Jump To Conclusion That All Vaccines, Except mRNA Shots, Are Not Working Against Omicron Variant Benzinga

10:05AM EST Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY(r) to Help Meet Continued Need for Vaccine Supply Business Wire

08:41AM EST EMA Head Says COVID Vaccines Clearly Less Effective Against Omicron; Says Data On Omicron Not At All Definitive But It's Clear That There Is A Drop In Vaccine Effectiveness Benzinga

07:36AM EST Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Monday an agreement has been reached with the European Commission (EC) and its member states to exercise an option to purchase more than 200 million additional doses of COMIRNATY, the companies' COVID-19 vaccine. Contractual details are currently being finalized. RTTNews

07:23AM EST Pfizer And BioNTech To Provide More Than 200 Mln Addl Doses Of COMIRNATY To EU In 2022 RTTNews

05:28AM EST U.S. Equity Futures, European Markets Fall Sharply Over Rising Omicron Concerns; Two U.S. Senators Test Positive for Covid-19; Moderna Said Booster Effective vs Omicron; Senator Manchin Says he Will Not Support Biden Spending Bill Benzinga

Dec 19, 2021

07:20PM EST New Jersey Democratic Senator Cory Booker Says He Has Tested Positive for Covid-19 Benzinga

05:16PM EST Massachusetts Senator Warren Tests Positive for Covid-19 Benzinga

Dec 17, 2021

04:16PM EST The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More Benzinga

12:37PM EST Pfizer Whale Trades For December 17 Benzinga

10:32AM EST Pfizer Says Is Currently Assuming COVID Will Transition To An Endemic Phase In 2024 Time Frame Benzinga

10:18AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 Benzinga

09:36AM EST Analyst Ratings For Pfizer Benzinga

09:34AM EST 'Pfizer saying that it plans to update its vaccine to be a three-dose vaccine, rather than two doses.' -Recent Tweet From POLITICO FDA Reporter Benzinga

09:34AM EST 'Pfizer saying that it plans to update its vaccine to be a three-dose vaccine, rather than two doses.' -Tweet From POLITICO FDA Reporter Benzinga

09:25AM EST Pfizer Expects COVID-19 Vaccine Sales Of Approximately $31B In 2022 Benzinga

08:10AM EST White House Says No New Recommendations Yet On COVID-19 Amid Omicron But Continuing To Assess Any Possible New Steps Benzinga

08:02AM EST Vera Therapeutics Acquires MAU868 From Pfizer To Treat BK Virus In Transplant Patients RTTNews

07:54AM EST The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx Benzinga

07:47AM EST Goldman Sachs Initiates Coverage On Pfizer with Neutral Rating, Announces Price Target of $51 Benzinga

07:31AM EST Vera Therapeutics Reports Purchase Of Monoclonal Antibody From Pfizer For $5M Upfront Payment, Potential Milestones For Up To $7M Benzinga

05:32AM EST Head of the European Commission Said European Union Governments Agreed to Order 180M+ Doses of Version Tailored to Protect Against Omicron Varian Benzinga

Dec 16, 2021

09:33PM EST U.S. Centers for Disease Control and Prevention or CDC recommends that people take the mRNA COVID-19 vaccines made by Pfizer and Moderna instead of Johnson & Johnson's single-shot COVID-19 vaccine due to a rare blood clotting disorder. RTTNews

08:46PM EST EMA's CHMP Issues Advice For Potential Early Use Of RTTNews

05:04PM EST Pfizer, BioNTech Submit Supplemental Biologics License Application For FDA Approval Of Comirnaty In Adolescents 12-15 Years Of Age Benzinga

03:45PM EST 'CDC advisory committee vote on whether to say mRNA #covid19 vaccines are preferred over J&J vaccine for everyone 18+: Yes: 15 No: 0' -Tweet From CNBC's Meg Tirrell Benzinga

01:57PM EST World Trade Organization Chief Says Parties Getting Close To Solution In Dispute Over COVID-19 Vaccine Rights Benzinga

01:45PM EST 'De Blasio says NYC looking at question of requiring boosters for teachers and other city employees "on the front burner," will say more soon' -NBC New York Report Benzinga

12:16PM EST CDC Says There Have Been 8 Reports To Vaccine Adverse Event Reporting System That Meet Definition Of Myocarditis Among Children Aged 5-11 Who Received COVID-19 Vaccine Benzinga

12:15PM EST U.S. CDC Says No Confirmed Reports Of Myocarditis In Vaccine Safety Datalink Monitoring System Among Children Aged 5-11 Who Received COVID-19 Vaccine Benzinga

10:30AM EST EMA Issues Advice for Potential Early Use of Pfizer's Novel COVID-19 Oral Antiviral Candidate Business Wire

10:05AM EST Pfizer Shares Quiet Following Circulation Of European Medicines Agency Listing For 'EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19,' Says 'Rolling review starts in parallel' Benzinga

Dec 15, 2021

11:34AM EST 'Our booster vaccine regimens work against omicron - at this time there's no need for a variant-specific booster," Dr Fauci says at @WHCOVIDResponse briefing' -Tweet From CNBC's Meg Tirrell Benzinga

11:31AM EST FDA Approves AbbVie's JAK Inhibitor Application For Active Psoriatic Arthritis Benzinga

11:27AM EST CDC's Walensky Says Will Release Vaccine, Booster Data On Thursday Benzinga

11:27AM EST CDC's Walensky Says Early Data Suggests Omicron Has A Doubling Time Of About 2 Days According To Early Research Benzinga

11:15AM EST European Medicines Committee Backs Johnson & Johnson's COVID-19 Booster Dose Benzinga

11:13AM EST Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back Benzinga

09:18AM EST Pfizer's Xeljanz Scores FDA Nod For Active Ankylosing Spondylitis Benzinga

08:03AM EST The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO Benzinga

07:25AM EST SVB Leerink Maintains Market Perform on Pfizer, Raises Price Target to $56 Benzinga

Dec 14, 2021

11:25PM EST LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA PR Newswire

05:11PM EST Pfizer Inc. (PFE) Tuesday said that the U.S. Food and Drug Administration has approved the supplemental New Drug Application for Xeljanz (tofacitinib) for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers. RTTNews

04:13PM EST U.S. FDA Approves Pfizer's XELJANZ For Treatment Of Active Ankylosing Spondylitis RTTNews

04:09PM EST Pfizer Reports FDA Approved Co.'s XELJANZ For Treatment Of Active Ankylosing Spondylitis Benzinga

04:08PM EST U.S. FDA Approves Pfizer's XELJANZ(r) (tofacitinib) for the Treatment of Active Ankylosing Spondylitis Business Wire

document.getElementById("FjdqWZ").onerror = function(){this.style.display='none';}; .dark-mode .x83HPj{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .x83HPj{ color: #333333; background-color: white; border: 2px solid #333333; }PFEPfizer Inc.stock NYSE

PFE
Pfizer Inc.
stock NYSE